TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
389,130
|
325,936
|
359,942 |
Financial expenses |
189
|
323
|
779 |
Earnings before taxes |
7,610
|
8,523
|
8,641 |
EBITDA |
6,810
|
5,704
|
8,966 |
Total assets |
100,967
|
73,931
|
58,112 |
Current assets |
96,463
|
70,118
|
54,325 |
Current liabilities |
80,294
|
54,615
|
44,410 |
Equity capital |
20,673
|
19,316
|
13,701 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
20.5%
|
26.1%
|
23.6% |
Turnover per employee |
129,710
|
108,645
|
119,981 |
Profit as a percentage of turnover |
2.0%
|
2.6%
|
2.4% |
Return on assets (ROA) |
7.7%
|
12.0%
|
16.2% |
Current ratio |
120.1%
|
128.4%
|
122.3% |
Return on equity (ROE) |
36.8%
|
44.1%
|
63.1% |
Change turnover |
61,515
|
-4,850
|
118,245 |
Change turnover % |
19%
|
-1%
|
49% |
Chg. No. of employees |
0
![]() |
0
|
3 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.